✍️The Pacific AA Group's 'Annual Staff Party 2024' was held at the end of the year at the Distribution Center in the Tharkeyta Industrial Zone, with great enthusiasm and joy.
Read More
We provide you with comprehensive, up-to-date information on the company; we have put together some pages that will give you information on our press releases, television interviews, photographs and the news & happenings at AA Medical.
03
Jan
✍️The Pacific AA Group's 'Annual Staff Party 2024' was held at the end of the year at the Distribution Center in the Tharkeyta Industrial Zone, with great enthusiasm and joy.
Read More
03
Jan
"ကျန်းမာ၊ ချမ်းသာပြီး အောင်မြင်မှုများနှင့်ပြည့်စုံသည့် ၂၀၂၅ နှစ်သစ်ကို ပိုင်ဆိုင်နိုင်ကြပါစေကြောင်း" Pacific-AA Group မိသားစုမှ ဆုမွန်ကောင်းတောင်းအပ်ပါသည်။
Read More
03
Jan
Pacific Medical Industries Ltd (PMI), Myanmar's first private, locally-owned pharmaceutical manufacturing company, held an event titled “Transform Your Vision into Reality by Becoming a Brand Owner” on Thursday, October 24, 2024, from 6:00 PM to 9:00 PM at the LOTTE HOTEL (Main Ballroom).
Read More
03
Jan
"ကျန်းမာချမ်းသာ ဘေးဘယာဝေးကွာခြင်းနှင့်ပြည့်စုံသော နှစ်သစ်အခါသမယကို ပိုင်ဆိုင်နိုင်ပါစေကြောင်း Pacific AA Group မိသားစုမှ ဆန္ဒပြု ဆုမွန်ကောင်းတောင်းအပ်ပါသည်။ "
Read More
03
Jan
" ဘေးရန်ကင်းကွာပြီး အေးချမ်းသာယာသည့် ခရစ္စမတ် နှင့် နှစ်သစ်ကူးအချိန်အခါသမယကို ပိုင်ဆိုင်နိုင်ပါစေကြောင်း Pacific-AA Group မိသားစုမှ ဆုမွန်ကောင်းတောင်းအပ်ပါတယ် "
Read More
03
Jan
At 11 a.m. on the 5th of February, 2023, AA Medical Products Ltd. held a Hybrid Webinar on Small Molecule in Rheumatology in Pyay Room of Novotel Hotel in Yangon.
Read More
03
Jan
Happy Chinese New Year 🐇🐇🐇 Gong Xi Fa Cai ! 🧧🧧🧧 Wishing you a prosperous, marvelous, blissful Lunar Year ahead ! Here’s to all the goodness to come!
Read More
03
Jan
May the celebrations of Christmas bring along many more opportunities for you to have a spectacular New Year ahead 🎄🎉❄️✨ Merry Christmas & Happy New Year 2023 !!!
Read More
03
Jan
💊 Pacific Medical Industries Ltd is delighted to announced that we have manufactured the Baricitnib oral pill in the name of the branded generic BARICPAC for patients severely impacted by COVID-19. BARICIPAC have also been approved by the Myanmar FDA under Drug Registration Certificate No. 2310ND016. 💊 A BARICIPAC pill contains 4mg of Barictinib. Under the guidance and authorization of the US FDA, it can be utilized by patients from ages 2 and above, and combined with anti-viral Remdesivir for patients battling severe bouts of COVID-19. This pill will shorten the length of treatment, as well as prevent the need for oxygen support and invasive lung ventilation.
Read More
03
Jan
Successful generic drug production of world’s latest Covid-19 treatment medicine called PAXLOVID (Nirmatrelvir 150mg; Ritonavir 100mg) which is the world’s latest oral medication for COVID-19 treatment, produced under the name “PACLOVID” domestically at our pharmaceutical factory: Pacific Medical Industries Ltd (PMI) 💊 Pacific Medical Industries (PMI) is pleased to announce the approval of PACLOVID (Nirmatrelvir 150mg; Ritonavir 100mg) by the Myanmar FDA with recommendation letter no. 2308ND012 for the use of PACLOVID in the mild to moderate coronavirus (COVID-19) in adults
Read More